Alnylam Pharmaceuticals
ALNY
#631
Rank
NZ$67.30 B
Marketcap
NZ$504.13
Share price
-1.01%
Change (1 day)
-1.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company